These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27959531)

  • 21. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
    Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
    Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation.
    Ou Y; Wang SJ; Jiang L; Zheng B; Gu W
    J Biol Chem; 2015 Jan; 290(1):457-66. PubMed ID: 25404730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of the serine and glycine pathway in cancer cells.
    Antonov A; Agostini M; Morello M; Minieri M; Melino G; Amelio I
    Oncotarget; 2014 Nov; 5(22):11004-13. PubMed ID: 25436979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?
    Li AM; Ye J
    Cancer Lett; 2020 Apr; 476():97-105. PubMed ID: 32032680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
    Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
    Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
    [No Abstract]   [Full Text] [Related]  

  • 26. Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.
    Zhou X; Tan Y; Gou K; Tao L; Luo Y; Zhou Y; Zuo Z; Sun Q; Luo Y; Zhao Y
    Bioorg Chem; 2021 Oct; 115():105159. PubMed ID: 34298241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and biochemical characterization of key enzymes in the cysteine and serine metabolic pathways of Acanthamoeba castellanii.
    Wu D; Feng M; Wang ZX; Qiao K; Tachibana H; Cheng XJ
    Parasit Vectors; 2018 Nov; 11(1):604. PubMed ID: 30477573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
    Zhang SL; He Y; Tam KY
    Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments.
    Spillier Q; Ravez S; Dochain S; Vertommen D; Thabault L; Feron O; Frédérick R
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.
    Tan Y; Zhou X; Gong Y; Gou K; Luo Y; Jia D; Dai L; Zhao Y; Sun Q
    Cell Mol Life Sci; 2021 Dec; 79(1):27. PubMed ID: 34971423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Serine in Cancer: Is Two Better Than One?
    Buqué A; Galluzzi L; Montrose DC
    Trends Cancer; 2021 Aug; 7(8):668-670. PubMed ID: 34219053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of serine metabolism in cancer.
    Mattaini KR; Sullivan MR; Vander Heiden MG
    J Cell Biol; 2016 Aug; 214(3):249-57. PubMed ID: 27458133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview.
    Pramono AA; Rather GM; Herman H; Lestari K; Bertino JR
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
    Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
    Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of a Self-Sustaining Cycle in Escherichia coli l-Serine Biosynthesis That Results in the Conservation of the Coenzyme, NAD.
    Grant GA
    Biochemistry; 2018 Mar; 57(11):1798-1806. PubMed ID: 29494135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
    Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
    Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.
    Marchesani F; Zangelmi E; Murtas G; Costanzi E; Ullah R; Peracchi A; Bruno S; Pollegioni L; Mozzarelli A; Storici P; Campanini B
    Protein Sci; 2023 Apr; 32(4):e4609. PubMed ID: 36851825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis of phosphoserine in the Methanococcales.
    Helgadóttir S; Rosas-Sandoval G; Söll D; Graham DE
    J Bacteriol; 2007 Jan; 189(2):575-82. PubMed ID: 17071763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
    Sheng H; Tang W
    Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
    Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E
    Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.